Table 2 Animal grouping and treatments for in vivo study exploring the role of TAMs in the anti-tumor therapeutic efficacy
Treatments | Groups (Mφ + / Mφ−) | ||||||
|---|---|---|---|---|---|---|---|
①| ② | ③ | ④ | ⑤ | ⑥ | ||
CNH-PG | (5 mg/mL, 20 μL per mouse) |  +  |  +  |  +  |  +  | ||
BMS-1 | (2.5 mg/kg body weight) |  +  |  +  |  +  | |||
LI | (808 nm, 0.78 W/cm2, 10 min) |  +  |  +  | ||||
PBS | (20 μL per mouse) |  +  | |||||